Table 4.
Characteristics | Survivors (n=44) (83%) | Nonsurvivors (n=9) (16.9%) | P |
---|---|---|---|
Type 2 diabetes mellitus | 15 (34%) | 3 (33.3%) | Not significant |
Hypertension | 24 (54.5%) | 6 (66.6%) | Not significant |
Coronary artery disease | 28 (63.6%) | 2 (22.2%) | <0.001 |
Acute renal failure | 6 (13.6%) | 3 (33.3%) | <0.001 |
Pneumonia | 9 (20.4%) | 5 (55.5%) | 0.02 |
ARDS (acute respiratory distress syndrome) | 10 (22.7%) | 6 (66.6%) | 0.01 |
GCS (Glasgow Coma Scale) | 11±4.6 | 7±3.9 | <0.001 |
ED stay (h) | 12±6.1 | 3±2.1 | 0.01 |
Hospitalization (days) | 7±2.3 | 10±4.1 | 0.04 |
ICU stay | 3±1.2 | 6±4.1 | Not significant |
Altered sensorium | 26 (59.09%) | 4 (44.4.%) | Not significant |
Increased sweating | 8 (18.1%) | 2 (22.2%) | Not significant |
Breathlessness | 6 (13.61%) | 5 (55.5%) | <0.001 |
Increased secretions | 8 (18.1%) | 4 (44.4.%) | 0.002 |
Jaundice | 4 (9.09%) | 3 (33.3%) | <0.001 |
Ionotropic support | 10 (22.7%) | 8 (88.8%) | <0.001 |
Ventilatory support | 2 (4.5%) | 7 (77.7%) | <0.001 |
Need for dialysis | 3 (6.8%) | 2 (22.2%) | <0.001 |